Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1998
11/10/1998US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors
11/10/1998US5834306 Tissue specific hypoxia regulated therapeutic constructs
11/10/1998US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus
11/10/1998US5834266 Regulated apoptosis
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834044 Provides enhanced in vivo oxidative defense indices and prevents or attenuates exercise induced in vivo oxidative stress
11/10/1998US5833984 Composition and method for preventing and treating inflammation with Immunoglobulin A
11/10/1998US5833967 Colloidal silica as a reinforcing agent of keratin substances
11/10/1998CA2114877C Preparation of carbonic anhydrase inhibitors
11/10/1998CA2006201C Substituted indole, benzofuran and benzothiophene derivatives as 5-lipoxygenase inhibitors
11/09/1998CA2237052A1 Substituted diaminocarboxylic acids
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998WO1998049326A1 Method for cleavage of fusion proteins
11/05/1998WO1998049305A1 Chimeric opg polypeptides
11/05/1998WO1998049302A1 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998049296A1 Human cerberus protein
11/05/1998WO1998049292A2 Polypeptides associated with activator receptors and their biological applications
11/05/1998WO1998049291A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways
11/05/1998WO1998049278A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND β-GLUCANOLYTIC ENZYMES
11/05/1998WO1998049197A1 Oligopeptidic inhibitors of elastases and methods of preparation thereof
11/05/1998WO1998049191A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
11/05/1998WO1998049170A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998WO1998049169A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998WO1998049168A1 Reverse-turn mimetics and methods relating thereto
11/05/1998WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998WO1998049161A1 Antithrombotic agents
11/05/1998WO1998049160A1 Antithrombotic agents
11/05/1998WO1998049157A1 Farnesyltransferase inhibiting quinazolinones
11/05/1998WO1998049152A1 Protease inhibitors
11/05/1998WO1998049146A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998WO1998049145A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998048827A1 Genes coding proteins for early liver development and their use in diagnosing and treating liver disease
11/05/1998WO1998048822A1 Improved methods for processing activated protein c
11/05/1998WO1998048818A1 Activated protein c formulations
11/05/1998WO1998048812A1 Use of anabolic steroid derivatives in the treatment of chronic heart failure
11/05/1998WO1998048810A1 Composition and methods using an eutomer
11/05/1998WO1998048809A1 Use of immunomodulating agents
11/05/1998WO1998048800A1 Antithrombotic agents
11/05/1998WO1998048799A1 Protease inhibitors
11/05/1998WO1998048798A1 Antithrombotic agents
11/05/1998WO1998048797A1 Antithrombotic agents
11/05/1998WO1998048795A1 Therapeutic treatment for skin disorders
11/05/1998WO1998048794A1 Antithrombotic agents
11/05/1998WO1998048786A1 AMINOTETRALINS AS 5-HT1Dα AGONISTS
11/05/1998WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998WO1998048784A2 Method and composition for modulating amyloidosis
11/05/1998WO1998048782A1 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
11/05/1998WO1998048630A1 Method of treating malignancies
11/05/1998WO1998043618A3 Use of cytoskeletal inhibitors for the prevention of restenosis
11/05/1998WO1998042737A3 Peptides for the treatment of systemic lupus erythematosus
11/05/1998WO1998037094A3 Secreted proteins and polynucleotides encoding them
11/05/1998WO1998034954A3 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
11/05/1998WO1998034602A3 Mediation of cytokines by melanin
11/05/1998WO1998033798A3 Pyrido[2,3-d]pyrimidines and 4-amino-pyrimidines as inhibitors of cell proliferation
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/05/1998DE19720162A1 Mittel zur Steigerung der Herzkraft Means of increasing the myocardial contractile force
11/05/1998DE19720151A1 Chimäre Oligonucleotide und ihre Verwendung Chimeric oligonucleotides and their use
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2289257A1 Therapeutic treatment for skin disorders
11/05/1998CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998CA2288897A1 Aminotetralins as 5-ht1d.alpha. agonists
11/05/1998CA2288351A1 Chimeric opg polypeptides
11/05/1998CA2288343A1 Secreted proteins and polynucleotides encoding them
11/05/1998CA2288308A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/05/1998CA2288154A1 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
11/05/1998CA2288144A1 Antithrombotic agents
11/05/1998CA2287993A1 Antithrombotic agents
11/05/1998CA2287989A1 Protease inhibitors
11/05/1998CA2287984A1 Antithrombotic agents
11/05/1998CA2287982A1 Antithrombotic agents
11/05/1998CA2287980A1 Antithrombotic agents
11/05/1998CA2287916A1 Polypeptides associated with activator receptors and their biological applications
11/05/1998CA2287906A1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptotic cell death pathways
11/05/1998CA2287901A1 Antithrombotic agents
11/05/1998CA2287567A1 Protease inhibitors
11/05/1998CA2287436A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998CA2286861A1 Method for cleavage of fusion proteins
11/05/1998CA2286232A1 Dna-binding pyrrole and imidazole polyamide derivatives
11/05/1998CA2285948A1 Method and composition for modulating amyloidosis
11/05/1998CA2278217A1 Phosphodiesterase 4-inhibiting diazepinoindolones
11/05/1998CA2258490A1 Novel internal ribosome entry site and vector containing same
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875569A1 A human sodium dependent phosphate transporter (IPT-1)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875563A2 Improved methods for processing activated protein C
11/04/1998EP0875513A1 Substituted heteroaromatic 5-HT 1F agonists
11/04/1998EP0875512A2 New naphthylpiperazine derivatives with antipsychotic activity
11/04/1998EP0875499A2 Process for the crystallisation of alkali metal salts of diformylamide
11/04/1998EP0875252A2 Activated protein C formulations
11/04/1998EP0875251A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
11/04/1998EP0875250A1 Use of an extract of Salvia officinalis to combat the Dupuytren's contracture
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998EP0874848A1 Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells
11/04/1998EP0874845A1 Pyrido (2,3-b) pyrazine derivatives
11/04/1998EP0874843A1 Novel substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases
1 ... 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 ... 1564